Please login to the form below

Not currently logged in
Email:
Password:

MSD appoints new UK head

Mike Nally moves from Swedish division
MSD MIke Nally

Merck Sharp and Dohme (MSD) has announced that Mike Nally is to take on the role of managing director of the company's operations in the UK and Ireland.

Nally will take over the role on January 1, 2014, moving from his current position as managing director of MSD in Sweden.

He replaces Deepak Khanna who has been appointed to a new senior VP role at MSD where he will lead the company's oncology efforts across Europe.

As previously announced, Khanna will also step down from his role as president of the Association of the British Pharmaceutical Industry (ABPI) to be replaced by Pfizer's Jonathan Emms.

Commenting on Nally's work in Sweden, MSD said that “he has led the company to become a more customer centric organisation in a dynamic, payer-based environment”.

10th December 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....